ArticleUltrasonography (Seoul, Korea)2025
Feasibility of high-resolution flow-mediated dilation using a 24-MHz probe to assess endothelial dysfunction: comparison of hypertensive and normotensive groups.
Article in Ultrasonography (Seoul, Korea), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeThis study investigated differences in endothelial cell dysfunction (ECD) and vascular response between hypertensive (HT) and non-hypertensive (NHT) individuals, as evaluated by high-resolution flow-mediated dilation (hrFMD) using a 24-MHz ultrasound probe.
methodsThe study included 31 participants in the HT group and 29 in the NHT group. Clinical data, laboratory findings, and carotid intima-media thickness (cIMT) were measured, as were brachial artery systolic and diastolic diameters at baseline and 30, 60, and 120 seconds after a 5-minute cuff occlusion. Based on these measurements, systolic (TERS) and diastolic (TERD) traditional expansion ratios (TER), as well as a new expansion ratio (NER), were calculated for each post-occlusion time point. Differences, correlations, and multivariable logistic regression analyses were used to evaluate associations between ECD and hrFMD indices, with odds ratios (ORs) and 95% confidence intervals (CIs) reported.
resultsAt 60 seconds, NER and TER values in the HT group were significantly lower than in the NHT group. Most participants in the NHT (22/29, 75.8%) and HT (21/31, 67.7%) groups exhibited peak vasodilation at NER60. NER60 was negatively correlated with age (r=-0.603, P<0.001), cIMT (r=-0.328, P=0.011), and systolic blood pressure (r=-0.277, P=0.032). NER60 was associated with hypertension-related ECD independently of major cardiovascular risk factors (OR, 0.025; 95% CI, 0.002 to 0.316; P=0.004).
conclusionIn hrFMD, NER60 was significantly lower in HT than in NHT participants and may represent a surrogate marker for impaired vascular reactivity associated with hypertension. However, its role in the direct detection of ECD requires further validation against established physiological criteria.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.